Sample | Title | Value | Rank |
GSM451635 | M15 - infected MBT/Pas fibroblasts (9 h post inf) | 427.9 | 89 |
GSM451636 | M16 - infected MBT/Pas fibroblasts (9 h post inf) | 403.7 | 88 |
GSM451637 | M17 - infected MBT/Pas fibroblasts (9 h post inf) | 322.4 | 86 |
GSM451632 | M11 - non-infected MBT/Pas fibroblasts | 319.6 | 85 |
GSM451633 | M12 - non-infected MBT/Pas fibroblasts | 297.4 | 84 |
GSM451634 | M13 - non-infected MBT/Pas fibroblasts | 376.6 | 87 |
GSM451629 | B15 - infected BALB/cByJ fibroblasts (9 h post inf) | 394.7 | 88 |
GSM451630 | B16 - infected BALB/cByJ fibroblasts (9 h post inf) | 473.1 | 90 |
GSM451631 | B17 - infected BALB/cByJ fibroblasts (9 h post inf) | 479.3 | 90 |
GSM451626 | B11 - non-infected BALB/cByJ fibroblasts | 487.8 | 90 |
GSM451627 | B12 - non-infected BALB/cByJ fibroblasts | 415.1 | 88 |
GSM451628 | B13 - non-infected BALB/cByJ fibroblasts | 506.9 | 90 |